DK0994890T3 - Benzimidazolderivater - Google Patents

Benzimidazolderivater

Info

Publication number
DK0994890T3
DK0994890T3 DK98936306T DK98936306T DK0994890T3 DK 0994890 T3 DK0994890 T3 DK 0994890T3 DK 98936306 T DK98936306 T DK 98936306T DK 98936306 T DK98936306 T DK 98936306T DK 0994890 T3 DK0994890 T3 DK 0994890T3
Authority
DK
Denmark
Prior art keywords
benzimidazole
Prior art date
Application number
DK98936306T
Other languages
English (en)
Inventor
John Charles Drach
Leroy B Townsend
Frank Leslie Boyd Jr
Stanley Dawes Chamberlain
Susan Mary Daluge
David Norman Deaton
Marc W Andersen
George Andrew Freeman
Original Assignee
Univ Michigan
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9711982.0A external-priority patent/GB9711982D0/en
Priority claimed from GBGB9714552.8A external-priority patent/GB9714552D0/en
Application filed by Univ Michigan, Glaxo Group Ltd filed Critical Univ Michigan
Application granted granted Critical
Publication of DK0994890T3 publication Critical patent/DK0994890T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98936306T 1997-06-10 1998-06-08 Benzimidazolderivater DK0994890T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9711982.0A GB9711982D0 (en) 1997-06-10 1997-06-10 Benzimidazole derivatives
GBGB9714552.8A GB9714552D0 (en) 1997-07-11 1997-07-11 Benzimidazole derivatives
PCT/EP1998/003380 WO1998056761A2 (en) 1997-06-10 1998-06-08 Benzimidazole derivatives

Publications (1)

Publication Number Publication Date
DK0994890T3 true DK0994890T3 (da) 2003-12-01

Family

ID=26311687

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98936306T DK0994890T3 (da) 1997-06-10 1998-06-08 Benzimidazolderivater

Country Status (35)

Country Link
US (1) US6455507B1 (da)
EP (1) EP0994890B1 (da)
JP (1) JP4548866B2 (da)
KR (1) KR20010020465A (da)
CN (1) CN1265665A (da)
AP (1) AP1262A (da)
AR (1) AR012964A1 (da)
AT (1) ATE246700T1 (da)
AU (1) AU740792C (da)
BR (1) BR9810745A (da)
CA (1) CA2293470C (da)
CO (1) CO4970737A1 (da)
DE (1) DE69816992T2 (da)
DK (1) DK0994890T3 (da)
EA (1) EA002305B1 (da)
EE (1) EE9900564A (da)
ES (1) ES2205527T3 (da)
HK (1) HK1024921A1 (da)
HR (1) HRP980303B1 (da)
HU (1) HUP0002224A3 (da)
ID (1) ID24054A (da)
IL (1) IL133285A0 (da)
IS (1) IS5285A (da)
MA (1) MA26504A1 (da)
MY (1) MY132872A (da)
NO (1) NO314847B1 (da)
NZ (1) NZ501415A (da)
OA (1) OA11230A (da)
PE (1) PE84099A1 (da)
PL (1) PL337773A1 (da)
PT (1) PT994890E (da)
SK (1) SK171499A3 (da)
TR (1) TR199903053T2 (da)
TW (1) TW565566B (da)
WO (1) WO1998056761A2 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990081940A (ko) 1996-01-23 1999-11-15 그레이엄 브레레톤, 레슬리 에드워즈 항바이러스제로서 변형된 벤즈이미다졸 누클레오시드
US6455506B1 (en) 1997-07-30 2002-09-24 Smithkline Beecham Corporation Lyxofuranosyl benzimidazoles as antiviral agents
DE19741715A1 (de) * 1997-09-22 1999-03-25 Hoechst Ag Pentopyranosyl-Nucleosid, seine Herstellung und Verwendung
GB0008939D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
MXJL03000027A (es) 2001-03-12 2004-04-30 Avanir Pharmaceuticals Compuestos de benzimidazol para modular la ige e inhibir la proliferacion celular.
AU2003270426A1 (en) 2002-09-12 2004-04-30 Avanir Pharmaceuticals PHENYL-INDOLE COMPOUNDS FOR MODULATING IgE AND INHIBITING CELLULAR PROLIFERATION
TWI276631B (en) 2002-09-12 2007-03-21 Avanir Pharmaceuticals Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation
US7094764B2 (en) * 2003-08-01 2006-08-22 Janssen Pharmaceutica N.V. Substituted benzimidazole-, Benztriazole-, and benzimidazolone-O-glucosides
WO2005049582A1 (en) * 2003-11-14 2005-06-02 Auspex Pharmaceuticals, Inc. Method of preparation of novel nucleoside analogs and uses
CA2598690C (en) * 2005-02-22 2011-11-15 The Regents Of The University Of Michigan Small molecule inhibitors of mdm2 and uses thereof
DE102005019549A1 (de) * 2005-04-25 2006-12-14 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Diaminobenzimidazol
WO2007070947A1 (en) * 2005-12-22 2007-06-28 Alchemia Ltd Antibacterial agents
US10238599B2 (en) 2006-01-19 2019-03-26 The Regents Of The University Of Michigan Composition and method for treating congenital cytomegalovirus induced hearing loss
US7951845B2 (en) 2006-01-19 2011-05-31 The Regents Of The University Of Michigan Composition and method of treating hearing loss
US8338397B2 (en) 2006-01-19 2012-12-25 The Regents Of The University Of Michigan Composition and method of treating side effects from antibiotic treatment
US9770433B2 (en) 2006-01-19 2017-09-26 The Regents Of The University Of Michigan Composition and method for treating tinnitus
US9889156B2 (en) 2006-01-19 2018-02-13 The Regents Of The University Of Michigan Method for treating noise-induced hearing loss (NIHL)
US8927528B2 (en) 2006-01-19 2015-01-06 The Regents Of The University Of Michigan Composition for treating hearing loss
US9919008B2 (en) 2006-01-19 2018-03-20 The Regents Of The University Of Michigan Method for treating age-related hearing loss (ARHL)
USRE46372E1 (en) 2006-01-19 2017-04-25 The Regents Of The Univerity Of Michigan Method for treating hearing loss
KR101654007B1 (ko) 2007-08-15 2016-09-05 아이오니스 파마수티컬즈, 인코포레이티드 테트라하이드로피란 핵산 유사체
WO2009100045A1 (en) * 2008-02-04 2009-08-13 Translational Genomics Research Institute Compounds, pharmaceutical compositions and methods of use of hydroxamic acid derivatives
US8530640B2 (en) 2008-02-07 2013-09-10 Isis Pharmaceuticals, Inc. Bicyclic cyclohexitol nucleic acid analogs
WO2010036613A1 (en) 2008-09-26 2010-04-01 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
MX2011004258A (es) 2008-10-22 2011-06-01 Merck Sharp & Dohme Derivados de bencimidazol ciclicos novedosos utiles como agentes anti-diabeticos.
AU2009309007A1 (en) 2008-10-29 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
CA2741672A1 (en) 2008-10-31 2010-05-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
EP2393825A2 (en) 2009-02-06 2011-12-14 Isis Pharmaceuticals, Inc. Oligomeric compounds and methods
WO2010090969A1 (en) 2009-02-06 2010-08-12 Isis Pharmaceuticals, Inc. Tetrahydropyran nucleic acid analogs
JP2013520502A (ja) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション 有用な抗糖尿病薬である新規な環状ベンズイミダゾール誘導体
EP2601204B1 (en) 2010-04-28 2016-09-07 Ionis Pharmaceuticals, Inc. Modified nucleosides and oligomeric compounds prepared therefrom
US8546344B2 (en) 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
WO2014134493A1 (en) * 2013-03-01 2014-09-04 Los Alamos National Security, Llc Broad spectrum antibiotic compounds and use thereof
DK3137476T3 (da) 2014-04-28 2019-11-18 Ionis Pharmaceuticals Inc Linker-modificerede oligomerforbindelser
US10077242B2 (en) * 2014-12-01 2018-09-18 Virginia Commonwealth University Convergent approach to the total synthesis of telmisartan via a suzuki cross-coupling reaction
RU2629670C2 (ru) * 2016-08-04 2017-08-31 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) 2-Амино-5,6-дифтор-1-(бета-D-рибофуранозил)-бензимидазол, способ получения и противовирусная активность его в отношении вируса герпеса простого 1-го типа
EP3907230A1 (en) 2020-03-30 2021-11-10 Biometrix Technology Inc. Novel benzimidazole derivatives, preparation method thereof and use thereof as anti-cancer agent comprising the same
KR102583547B1 (ko) 2020-03-30 2023-10-06 (주)바이오메트릭스 테크놀로지 신규한 벤지미다졸 유도체, 이의 제조방법 및 이의 항암제 용도
CN114096549A (zh) * 2020-06-23 2022-02-25 博美利克斯技术公司 新型苯并咪唑衍生物、其制备方法及其作为抗癌剂或者抗病毒剂的用途
KR102449266B1 (ko) 2020-06-23 2022-09-30 (주)바이오메트릭스 테크놀로지 항암 활성 그리고 항바이러스 활성을 갖는 신규한 벤지미다졸-탄수화물 결합체 화합물(Benzimidazole carbohydrate conjugate compound) 및 이의 제조 방법
KR102342313B1 (ko) 2021-08-27 2021-12-24 (주)바이오메트릭스 테크놀로지 벤지미다졸-탄수화물 결합체 화합물을 포함하는 미셀, 이의 제조방법, 이의 항암제 또는 항바이러스제로서의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1491244A (fr) 1966-03-09 1967-08-11 Nouveaux benzimidazoles solubles
FR1476350A (fr) 1966-04-18 1967-04-07 Yale & Towne G M B H Ferme-porte automatique à frein
US3655901A (en) 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
DE2130030A1 (de) 1971-06-18 1972-12-21 Bayer Ag Fungizide und bakterizide Mittel
ES482789A0 (es) 1978-08-25 1980-12-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos bencimidazoles sustituidos en posicion 5 o 6 con un anillo de piridazinona
DK405988A (da) 1987-07-29 1989-01-30 Hoffmann La Roche Benzimidazolderivater
IT1226100B (it) 1988-07-07 1990-12-10 Dompe Farmaceutici Spa Derivati benzimidazolici farmacologicamente attivi.
US5248672A (en) 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
ZA923641B (en) 1991-05-21 1993-02-24 Iaf Biochem Int Processes for the diastereoselective synthesis of nucleosides
EP0521463A3 (en) 1991-07-04 1993-04-14 Hoechst Aktiengesellschaft Substituted cyclic cycloalkyltriols, process, intermediates for their preparation and their use as antiviral and antiparasitic agents
GB9205071D0 (en) 1992-03-09 1992-04-22 Wellcome Found Therapeutic nucleosides
WO1994008456A1 (en) 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
US5399580A (en) 1993-03-08 1995-03-21 Burroughs Wellcome Co. Therapeutic nucleosides-uses
GB9413724D0 (en) 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides

Also Published As

Publication number Publication date
PL337773A1 (en) 2000-09-11
ID24054A (id) 2000-07-06
EA199901031A1 (ru) 2000-06-26
AP1262A (en) 2004-03-16
CN1265665A (zh) 2000-09-06
EE9900564A (et) 2000-06-15
OA11230A (en) 2003-07-09
NO996086L (no) 2000-02-09
NZ501415A (en) 2001-10-26
HK1024921A1 (en) 2000-10-27
PT994890E (pt) 2003-11-28
MA26504A1 (fr) 2004-12-20
AP9901707A0 (en) 1999-12-31
ES2205527T3 (es) 2004-05-01
TW565566B (en) 2003-12-11
EP0994890A2 (en) 2000-04-26
JP4548866B2 (ja) 2010-09-22
HUP0002224A1 (hu) 2001-04-28
AU8536098A (en) 1998-12-30
MY132872A (en) 2007-10-31
BR9810745A (pt) 2001-03-13
EA002305B1 (ru) 2002-02-28
CA2293470C (en) 2008-05-13
US6455507B1 (en) 2002-09-24
HRP980303A2 (en) 1999-04-30
TR199903053T2 (xx) 2000-11-21
EP0994890B1 (en) 2003-08-06
IS5285A (is) 1999-12-06
JP2002504105A (ja) 2002-02-05
DE69816992T2 (de) 2004-07-22
AU740792B2 (en) 2001-11-15
CO4970737A1 (es) 2000-11-07
NO314847B1 (no) 2003-06-02
ATE246700T1 (de) 2003-08-15
IL133285A0 (en) 2001-04-30
NO996086D0 (no) 1999-12-09
WO1998056761A2 (en) 1998-12-17
HRP980303B1 (en) 2002-08-31
SK171499A3 (en) 2000-08-14
DE69816992D1 (en) 2003-09-11
AU740792C (en) 2003-01-23
KR20010020465A (ko) 2001-03-15
CA2293470A1 (en) 1998-12-17
HUP0002224A3 (en) 2003-05-28
US20020094963A1 (en) 2002-07-18
PE84099A1 (es) 1999-09-24
AR012964A1 (es) 2000-11-22
WO1998056761A3 (en) 1999-04-15

Similar Documents

Publication Publication Date Title
DK0994890T3 (da) Benzimidazolderivater
DE69840589D1 (de) erungsvorrichtung
DE69802795D1 (de) Präsentiervorrichtung
DE69839459D1 (de) Gehrungssägeschwenklagerfestspannvorrichtung
DE69821393D1 (de) Leitweglenkungsproxy
DE69841884D1 (de) Kabinenkommunikationsssystem
DE69824399T2 (de) Auswischbare tinten
DE69822175D1 (de) Reibe
DE69822025D1 (de) Schmelzfixierrollengehäuse
DE69829297D1 (de) Schnuller
DE69832487D1 (de) Bewässernverfahren
ATA112597A (de) Snowboard - bindung
DE69804271D1 (de) Polymer-Isolator
FI972138A0 (fi) Returtraog i bestrykningsanordning
DE69827113D1 (de) Kabelführung
FI972997A0 (fi) Anordning i en sugsamlarvagn
FI971123A0 (fi) Foervarings- och transportredskap i synnerhet foer pappersprodukter
FI971698A0 (fi) Klingstyrenhet i en cirkelsaog
FI974354A0 (fi) Kvaevereducering i avloppsvatten
FI974373A0 (fi) Avgasutlopp i utombordsmotorer
FI974635A0 (fi) I vaermebatteri integrerbar ventilkonstruktion
FI972891A0 (fi) I en vaeggkonstruktion infaellbart faerdigt elkanalnaet
FI972640A0 (fi) Gapformare i en pappersmaskin/kartongmaskin
BR9701099A (pt) Acertrol i
FI971651A0 (fi) Spaormaskin i en elmaskin